Dr. Jaslow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1100 Walnut St
Fl 3
Philadelphia, PA 19107Phone+1 215-955-8874- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1999 - 2002
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
- Icahn School of Medicine at Mount SinaiClass of 1996
Certifications & Licensure
- NJ State Medical License 2017 - 2025
- PA State Medical License 2002 - 2024
- DE State Medical License 2017 - 2023
- NY State Medical License 1997 - 2002
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Clinical Trials
- Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer Start of enrollment: 2011 Dec 01
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
- Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2013 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsGenomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.Maysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong, Daniel P Silver, Frederick Fellin, Rebecca Jaslow, AnaMaria Lopez, Terrence Cescon, Wei Jiang, Rona...> ;Cancers. 2022 Jun 10
- 22 citationsPrognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M. Abu-Khalaf, Daniel P. Silver, Juan P. Palazzo, Geetha Jagannathan, Frederick M. Fellin, Saveri Bhattacharya, ...> ;Breast Cancer Research and Treatment. 2020 May 4
- 1 citationsEvaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study.Talya S. Laufer, Bryan Lerner, Anett Petrich, Anna Quinn, Leah Ernst, Alicin Roop, Janet Knoblauch, Nick C Leasure, Rebecca Jaslow, Sarah E. Hegarty, Amy Leader, Andre...> ;JMIR Cancer. 2019 Dec 20
- Join now to see all
Hospital Affiliations
- Lankenau Medical CenterWynnewood, Pennsylvania
- Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: